MERCER GLOBAL ADVISORS INC /ADV

Position in CRDF — Cardiff Oncology, Inc.

CIK 853758 DENVER, CO

Position in CRDF

as of Jun 30, 2026 · filed Aug 19, 2026 Compact

Position Value

$16,581

-$190,418 QoQ

Shares Held

12,755

-91.4% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#66

of 104 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 56% Shared 0% None 44%

Healthcare · as of Jun 30, 2026

MERCER GLOBAL ADVISORS INC /ADV holds $303,308,584 across 140 Biotechnology names. CRDF ranks #139 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	941,283	$124,936,492
2	CAPR	Capricor Therapeutics, Inc.	802,732	$19,329,786
3	ORMP	Oramed Pharmaceuticals Inc.	3,810,540	$18,328,697
4	VRTX	Vertex Pharmaceuticals Inc / Ma	30,705	$15,252,094
5	INCY	Incyte Corp	116,207	$13,173,225
6	REGN	Regeneron Pharmaceuticals, Inc.	20,126	$12,549,366
7	EXEL	Exelixis, Inc.	176,339	$9,594,604
8	CORT	Corcept Therapeutics Inc	102,823	$8,940,459

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$16,581	12,755	-91.4%	Shares	Sole	2026-08-19
2022-12-31	$206,999	147,857	0.0%	Shares	Sole	2023-02-09
2022-09-30	$227,699	147,857	0.0%	Shares	Sole	2022-11-15
2022-06-30	$325,285	147,857	0.0%	Shares	Sole	2022-08-10
2022-03-31	$366,685	147,857	-21.5%	Shares	Sole	2022-05-10
2021-12-31	$1,132,025	188,357	+8.7%	Shares	Sole	2022-02-04
2021-09-30	$1,154,557	173,357	+3.3%	Shares	Sole	2021-11-10
2021-06-30	$1,116,249	167,857	+6.3%	Shares	Sole	2021-08-10
2021-03-31	$1,461,755	157,857	+16.2%	Shares	Sole	2021-08-10
2020-12-31	$2,443,941	135,850	0.0%	Shares	Sole	2021-02-12
2020-09-30	$1,927,711	135,850	+0.1%	Shares	Sole	2020-12-10
2020-06-30	$679,606	135,650	—	Shares	Sole	2020-08-10
No filing history on record for this holder in this stock.